References
- Akhtar AM, Arif MA, Kanwal S, Majeed S. Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan. J Pak Med Assoc. 2016 Aug;66(8):989–993.
- Bhattacherjee S, Datta S. Primary multi drug resistant extra-pulmonary tuberculosis presenting as cervical lymphadenitis. J Glob Infect Dis. 2014;6(2):91–92. https://doi.org/10.4103/0974-777X.132066
- Ejaz M, Siddiqui AR, Rafiq Y, Malik F, Channa A, Mangi R, Habib F, Hasan R. Prevalence of multi-drug resistant tuberculosis in Karachi, Pakistan: identification of at risk groups. Trans R Soc Trop Med Hyg. 2010 Aug;104(8):511–517. https://doi.org/10.1016/j.trstmh.2010.03.005
- GLI. Mycobacteriology Laboratory Manual [Internet]. Global Laboratory Initiative a Working Group of the Stop TB Partnership; 2014 [cited 2019 Oct 3]. Available from http://www.who.int/tb/laboratory/mycobacteriology-laboratory-manual.pdf
- Grange JM, Zumla A. The global emergency of tuberculosis: what is the cause? J R Soc Promot Health. 2002 Jun;122(2):78–81. https://doi.org/10.1177/146642400212200206
- Hoa NB, Nhung NV, Khanh PH, Hai NV, Quyen BTT. Adverse events in the treatment of MDR-TB patients within and outside the NTP in Pham Ngoc Thach hospital, Ho Chi Minh City, Vietnam. BMC Res Notes. 2015 Dec;8(1):809. https://doi.org/10.1186/s13104-015-1806-4
- Javaid A, Hasan R, Zafar A, Ghafoor A, Pathan AJ, Rab A, Sadiq A, Akram CM, Burki I, Shah K, et al. Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan. Int J Tuberc Lung Dis. 2008 Mar;12(3):326–331.
- Khan MT, Malik SI, Ali S, Sheed Khan A, Nadeem T, Zeb MT, Masood N, Afzal MT. Prevalence of pyrazinamide resistance in Khyber Pakhtunkhwa, Pakistan. Microb Drug Resist. 2018 Nov; 24(9):1417–1421. https://doi.org/10.1089/mdr.2017.0234
- Neyrolles O, Quintana-Murci L. Sexual inequality in tuberculosis. PLoS Med. 2009 Dec 22;6(12):e1000199. https://doi.org/10.1371/journal.pmed.1000199
- NTP. Vision 2020 – National TB Control Strategic Plan [Internet]. Islamabad (Pakistan): National TB Control Program; 2014 [cited 2019 Oct 3]. Available from http://www.ntp.gov.pk/uploads/Vision_2020_National_Strategic_Plan.pdf
- NTP. National Guidelines for Diagnosis and Management of Tuberculosis in Pakistan [Internet]. Islamabad (Pakistan): National TB Control Program; 2015 [cited 2019 Oct 3]. Available from http://ntp.gov.pk/uploads/national_guideline_on_tb_case_management_rev_jan_2015.pdf
- O’Donnell MR, Zelnick J, Werner L, Master I, Loveday M, Horsburgh CR, Padayatchi N. Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South Africa. Emerg Infect Dis. 2011 Oct;17(10):1942–1945. https://doi.org/10.3201/eid1710.110105
- Wattal C, Raveendran R, Oberoi JK. Multidrug-resistant pulmonary and extrapulmonary tuberculosis: A 13 years retrospective hospital-based analysis. Indian J Med Res. 2015;142(5):575–582. https://doi.org/10.4103/0971-5916.171285
- Tahseen S, Qadeer E, Khanzada FM, Rizvi AH, Dean A, Van Deun A, Zignol M. Use of Xpert® MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan. Int J Tuberc Lung Dis. 2016 Apr 01;20(4):448–455. https://doi.org/10.5588/ijtld.15.0645
- Ullah I, Javaid A, Tahir Z, Ullah O, Shah AA, Hasan F, Ayub N. Pattern of drug resistance and risk factors associated with development of drug resistant Mycobacterium tuberculosis in Pakistan. PLoS One. 2016 Jan 25;11(1):e0147529. https://doi.org/10.1371/journal.pone.0147529
- Ullah I, Shah AA, Basit A, Ali M, Khan A, Ullah U, Ihtesham M, Mehreen S, Mughal A, Javaid A. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study. BMC Infect Dis. 2016 Dec;16(1):413. https://doi.org/10.1186/s12879-016-1745-2
- WHO. WHO Global tuberculosis report 2019 [Internet]. Genewa (Switzerland): World Health Organization; 2019 [cited 2019 Dec 20]. Available from http://www.who.int/tb/publications/global_report/en/
- Zignol M, Dean AS, Falzon D, van Gemert W, Wright A, van Deun A, Portaels F, Laszlo A, Espinal MA, Pablos-Méndez A, et al. Twenty years of global surveillance of antituberculosis-drug resistance. N Engl J Med. 2016 Sep 15;375(11):1081–1089. https://doi.org/10.1056/NEJMsr1512438
- Daniel TM. The history of tuberculosis. Respir Med. 2006 Nov; 100(11):1862–1870. https://doi.org/10.1016/j.rmed.2006.08.006